Avalo Therapeutics

Founded 2011 · CIK 0001534120 · Biotech · Public

Anti-IL-1beta monoclonal antibody therapeutic

avalotx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$182M
6 Form D · Apr 2024
30 months since last filing
Contracts
—
No federal contracts on record
Patents
28
2 granted · 26 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$22,137,301
Private capital raisedForm D · SEC$6,805,883
Private capital raisedForm D · SEC$16,259,016
Private capital raisedForm D · SEC$1,000,000
Private capital raisedForm D · SEC$5,000,000
Private capital raisedForm D · SEC$130,601,986
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2385HiberCell——
2386RaeSedo, LLC——
2387Rakuten Medical, Inc.—$887M
2388Avalo Therapeutics—$182M
2389MOCKV SOLUTIONS INC.——
2390SERPIN PHARMA, LLC——
2391ZENO MANAGEMENT, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 41 related persons
  • Thomas AasenDirector
  • THOMAS AASENDirector
  • June Almenoff, M.D., Ph.D.Director
  • Sol BarerDirector
  • Eugene BauerDirector
  • EUGENE BAUERDirector
  • Isaac BlechDirector
  • ISAAC BLECHDirector
  • John CatsimatidisDirector
  • Mitchell ChanDirector
  • Bernadine FraserExecutive Officer
  • Jonathan Goldman, M.D.Director
  • Phil GutryDirector
  • PHIL GUTRYDirector
  • Uli HacksellDirector · Executive Officer
  • ULI HACKSELLDirector · Executive Officer
  • John KaiserExecutive Officer
  • JOHN KAISERExecutive Officer
  • Aaron KantoffDirector
  • Gilla Kaplan, Ph.D.Director
  • Karen KrumeichExecutive Officer
  • Ronald MarcusExecutive Officer
  • RONALD MARCUSExecutive Officer
  • Reza MazhariExecutive Officer
  • Mariam MorrisExecutive Officer
  • MARIAM MORRISExecutive Officer
  • Garry Neil, M.D.Director · Executive Officer
  • Federica O'BrienExecutive Officer
  • Blake PatersonDirector · Executive Officer
  • Magnus PerssonDirector
  • MAGNUS PERSSONDirector
  • Magnus Persson, M.D., Ph.D.Director
  • Sharon RowlandExecutive Officer
  • Behshad SheldonDirector
  • Cary SucoffDirector
  • Cary Sucoff, Jr.Director
  • Mayukh SukhatmeDirector
  • Christopher SullivanExecutive Officer
  • Frank TortiDirector
  • Samantha TruexDirector
  • James VornovExecutive Officer

Patents

USPTO · 2 granted of 28

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.